Eli Lilly's Jardiance improves CKD kidney disease

https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-boehringer-say-jardiance-slows-kidney-disease-progression-trial-2022-11-04/?fbclid=IwAR2E6dP8r7dgmB8JzJMHFdU_b15Zq71bxdEUjTz6CLAI7EcKMCBE4g8j-NU

New diabetic medication heavily promoted in TV ads also benefits chronic kidney disease which can lead to kidney failure and the need for dialysis.

“Jardiance cut the risk of kidney disease progression and cardiovascular death by 28%, citing results from a late-stage trial which included people with and without diabetes.”